Physician profile
Jorge A Gilbert
NPI 1205831377
$2,126.18
in general payments reported to CMS, 2019-2025
12 companies · $606 in 2025
The $606 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.13 · 2020: $12.32 · 2021: $57.83 · 2022: $153 · 2023: $162 · 2024: $1,059 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,810 · Education: $16.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,810.48 |
| Education | $16.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $958.16 | 2024-2025 | Zenpep |
| Genzyme Corporation | $483.82 | 2022-2025 | |
| Ferring Pharmaceuticals INC. | $124.13 | 2023 | Rebyota |
| Regeneron Healthcare Solutions, INC. | $123.15 | 2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $84.31 | 2019-2022 | |
| Abbvie INC. | $83.29 | 2021-2023 | |
| Gilead Sciences, INC. | $64.01 | 2019-2021 | |
| Ipsen Biopharmaceuticals, INC | $61.63 | 2025 | Iqirvo |
| Phathom Pharmaceuticals, INC. | $61.49 | 2025 | Voquezna |
| Celltrion USA INC. | $52.11 | 2025 | Vegzelma |
| Nestle Healthcare Nutrition INC. | $16.11 | 2023 | |
| Pfizer INC. | $13.97 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.